title: Recurrent radiation necrosis in the brain  following stereotactic radiosurgery.
authors.affiliation: Harvard Medical School, Boston, Massachusetts.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Parker
authors.affiliation: Department of Neurosurgery, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts.
authors.forename: Ian F
authors.initials: IF
authors.lastname: Dunn
authors.affiliation: Department of Pathology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts.
authors.forename: Shakti H
authors.initials: SH
authors.lastname: Ramkissoon
authors.affiliation: York Hospital Oncology, York, Maine.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Eneman
authors.affiliation: Department of Medical Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Rabin
authors.affiliation: Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts. Electronic address: narvold@partners.org.
authors.forename: Nils D
authors.initials: ND
authors.lastname: Arvold
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D001929:Brain Edema / Q000209:etiology; D001932:Brain Neoplasms / Q000556:secondary* / Q000601:surgery*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology*; D003399:Craniotomy / Q000379:methods; D000069347:Erlotinib Hydrochloride / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology*; D009336:Necrosis / Q000209:etiology*; D011832:Radiation Injuries / Q000473:pathology; D016634:Radiosurgery / Q000009:adverse effects*
chemical_list: D000069347:Erlotinib Hydrochloride